Acute heart failure
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study (The consent from their parents or legal guardians is needed for the patients with dementia.)
Exclusion criteria
Exclusion criteria: Patients with liver disorder Patients with past history of removal of stomach Patients who is taking rivastigmine or rikkunshito Patients with anorexia or severe obesity (BMI>35) Patients with endocrine disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between plasma ghrelin level and serum butyrylcholinesterase level | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Vital signs: blood pressure, heart rate, body weight 2) Blood biomarkers: Albumin, prealbumin, T-chol, LDL-chol, HDL-chol, TG, BNP, NT-proBNP, hs-tropI, high sensitive CRP 3) Transthoracic echocardiography: LVEF, LVDd/Ds, E/e', LAD, LVEDV, LVESV, LV mass, TAPSE, RVEF, LA volume 4) Cardiac MIBG imaging: H/M MIBG uptake ratio on the delayed images, washout rate of cardiac MIBG 5) Body composition (bioimpedance method) 6) Electrocardiogram 7) Appetite score | — |
Countries
Japan
Contacts
Osaka General Medical Center Department of Cardiology